Not everyone is a fan of exercise, and you've probably heard more than a few jokes from people who say they're "allergic" to ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...

Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are ...

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL ...

Jeanetta has been feeling poorly and never knew why until recently.

Jasper Therapeutics, Inc.’s JSPR share price has surged by 7.55%, which has investors questioning if this is right time to sell.

Cogent Biosciences, Inc. topline results for phase 2/3 studies on bezuclastinib targeting systemic mastocytosis & GIST are ...

According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal ...

A woman from Kenosha, Wisconsin, opens up about her harrowing journey living with multiple food allergies and a mysterious ...

Joan Smith spent almost 40 years believing she suffered from severe allergies. Medical professionals frequently dismissed her concerns until a concerning episode made her seek out more answers.

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.